http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2180624-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3899a93c972ce60b070fca823112248 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-06 |
| filingDate | 1996-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec09b04f4ac78d61cb7b8b8bf3a741a1 |
| publicationDate | 2006-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2180624-C |
| titleOfInvention | Diphenyl-1,2,3-thiadiazoles as anti-inflammatory agents |
| abstract | The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. (see formula I) The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8247423-B2 |
| priorityDate | 1995-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 233.